HHS Articles, Harte-Hanks, Inc. - From 10/26/23

The Department of Health and Human Services disclosed a heavily redacted letter sent to the DEA concerning its recommendations for marijuana resche...

Former DEA chiefs and retired White House drug czars are expressing concerns over the possible rescheduling of cannabis. In a letter...

Congressional lawmakers from both sides of the aisle introduced a bicameral bill calling for further federal evaluation of kratom’s health an...

Attorney Matthew C. Zorn filed a complaint Friday in the U.S. District Court in Washington, D.C. against the Dept of Healt...

Senator Cynthia Lummis (R) and her colleague Senator Steve Daines (R), presented a bill to block cannabis legalization without congr...

The American Council of Cannabis Medicine (ACCM) supports the Health and Human Services (HHS) recommendation to reclassify cannabis from a Sch...

Tilray Brands (NASDAQ: TLRY) chairman and CEO Irwin D. Simon says his company is set to capitalize on possible cannabis le...

The case around the DEA's decision to terminate the employment of a special agent in 2020 after testing positive for THC is heating u...

Could the future of healthcare be intertwined with cannabis-based medicines? A recent report by Prohibition Partners, a data, media and tech c...

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's fut...